Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis
Authors:
- 11 August 2016
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 76 (9) , 789-797
Abstract
We aimed to evaluate the relationship between circulating blood adipokine levels and systemic sclerosis (SSc). We conducted a meta-analysis on serum/plasma adiponectin, leptin, or resistin levels in patients with SSc and controls, and performed a subgroup analysis based on ethnicity and/or disease type. Eleven studies (511 patients with SSc and 341 controls) were included in the meta-analysis. Meta-analysis revealed that adiponectin levels were significantly lower in patients with SSc than in controls (standardized mean differences [SMD] = −0.638; 95 % confidence intervals [CI] = −1.154, −0.122; P = 0.015). Stratification by ethnicity showed a low adiponectin level associated with SSc in Caucasians (SMD = −0.439; 95 % CI = −1.092, −0.213; P = 0.187) and Asians (SMD = −1.006; 95 % CI = −2.031, −0.019; P = 0.055), although this result was not statistically significant. Stratification by disease type revealed that the adiponectin level was significantly lower in the diffuse SSc, but not limited SSc, group than in the control (diffuse: SMD = −1.445; 95 % CI = −2.276, −0.614; P = 0.001; limited: SMD = 0.188; 95 % CI = −0.064, 0.439; P = 0.144). Meta-analysis showed no association between leptin levels and SSc (SMD = −0.029; 95 % CI = −1.362, 1.304; P = 0.966), and no association between resistin levels and SSc (SMD = 0.202; 95 % CI = −0.091, 0.496; P = 0.177). Our meta-analysis revealed a significantly lower circulating adiponectin level in patients with SSc than in controls. This difference was apparent in the diffuse type of SSc, but not in the limited type. However, circulating leptin and resistin levels were not different between patients with SSc and healthy controls.Keywords
This publication has 39 references indexed in Scilit:
- State of the art paper Biochemistry of adipose tissue: an endocrine organArchives of Medical Science, 2013
- The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapyArthritis Research & Therapy, 2012
- Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?Arthritis Research & Therapy, 2012
- Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patientsExperimental Dermatology, 2011
- Role of Leptin in the Activation of Immune CellsMediators of Inflammation, 2010
- Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysisLupus, 2010
- Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivoJournal of Clinical Investigation, 2007
- Towards a pro-inflammatory and immunomodulatory emerging role of leptinRheumatology, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986